J Mol Neurosci, 2008 · DOI: 10.1007/s12031-008-9090-6 · Published: November 1, 2008
Vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are expressed in the neural pathways regulating the lower urinary tract. VIP-immunoreactivity (IR) is present in afferent and autonomic efferent neurons innervating the bladder and urethra, whereas PACAP-IR is present primarily in afferent neurons. These observations raise the possibility that VIP or PACAP have a role in the control of normal or abnormal voiding.
VIP and PACAP pathways could be targeted for treating urinary dysfunctions.
Species-specific responses to VIP and PACAP highlight the need for tailored treatments.
Understanding VIP/PACAP's role post-SCI can improve bladder function recovery strategies.